Due out on January 29, 2026 in Japan. Kyouran Makaism is a brand-new 3D action RPG from an all-star team consisting of director Shunsuke Minowa, character designer Takehito Harada, and composer Tenpei ...

Hackers planted malicious code in open source software packages with more than 2 billion weekly updates in what is likely to be the world’s biggest supply-chain attack ever. “Sorry everyone, I should ...

The Department of Homeland Security’s Customs and Border Protection agency has issued a draft solicitation to seek industry feedback for a blanket purchase agreement supporting the Traveler Processing ...

Apple released iOS 18.6.2 on Aug. 20 to patch a zero-day vulnerability Apple said may have been used in an "extremely sophisticated attack against specific targeted ...

Aug 25 (Reuters) - Thoma Bravo will acquire Verint Systems (VRNT.O), opens new tab in a $2 billion deal, including debt, the customer engagement platform said on Monday, marking the latest software ...

What if your coding tools weren’t just tools, but collaborators? Imagine a development environment so intelligent it doesn’t just assist, it anticipates, adapts, and automates. Enter Warp 2.0, the new ...

TL;DR: HP's new HyperX audio lineup features the premium Cloud Alpha 2 Wireless headset with pro-grade sound, 250-hour battery life, and dual Bluetooth/2.4 GHz connectivity. The affordable Cloud ...

From the development team behind the Yomawari series, Hono Gurashi no Niwa is a life simulation game set in a nostalgic rural village. Farm and take care of livestock, enjoy activities like fishing ...

Morgan Stanley estimates that AI software spending will increase by 580% over the next three years to top $400 billion by the end of 2028. AppLovin has recently been one of the best executors in the ...

DJI products are packed with intelligent features, but like any high-tech gadget, they sometimes need a helping hand. For that, there's DJI Assistant 2, desktop software that functions like a utility ...

- ATG-022 is Antengene's CLDN18.2 antibody-drug conjugate; KEYTRUDA ® (pembrolizumab) is MSD's anti-PD-1 therapy. ATG-022 is uniquely positioned in the global landscape, with data supporting ...